The Union Cabinet chaired by Prime Minister Narendra Modi today has approved establishment of two new All India Institute of Medical Sciences (AIIMS) at Madurai, Tamil Nadu at a cost of Rs 1,264 crore and Bibinagar, Telangana at a cost of Rs 1,028 crore. The AIIMS will be set up under Pradhan MantriSwasthya Suraksha Yojana (PMSSY).
The Union Cabinet has also given its approval for creation of one post of Director in the basic pay of Rs 2,25,000/- (fixed) plus NPA (however pay + NPA would not exceed Rs 2,37,500) for each of the above two AIIMS. Some of the benefits include, new AIIMS will add 100 UG (MBBS) seats and 60 B.Sc. (Nursing) seats. Each new AIIMS will have 15-20 Super Specialty Departments. Each new AIIMS will add around 750 hospital beds. As per data of current functional AIIMS, it is expected that each new AIIMS would cater to around 1500 Outdoor patients per day and around 1000 Indoor patients per month.
Establishment of new AIIMS involves creation of Hospital, Teaching Block for medical & nursing courses, residential complex and allied facilities/services, broadly on the pattern of AIIMS, New Delhi and other six new AIIMS taken up under Phase-I of PMSSY. The objective is to establish the new AIIMS as Institutions of National Importance for providing quality tertiary healthcare, medical education, nursing education and research in the Region. The proposed institution shall have a hospital with capacity of 750 beds which will include Emergency / Trauma Beds, AYUSH Beds, Private Beds and ICU Speciality and Super Speciality beds. In addition, there will be a Medical College, AYUSH Block, Auditorium, Night Shelter, Guest House, Hostels and residential facilities. The establishment of the new AIIMS will create capital assets for which requisite specialized manpower will be created, based on the pattern of the six new AIIMS, for their maintenance and upkeep. The recurring cost on these Institutions shall be met through Grant-in-Aid to them from Plan Budget Head of PMSSY of Ministry of Health and Family Welfare.